AP
RMD icon

AHL Partners’s ResMed RMD Stock Holding History

AHL Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9.22M Buy
108,861
+15,507
+17% +$1.28M 0.14% 253
2017
Q3 		$7.18M Buy
93,354
+51,991
+126% +$3.98M 0.13% 288
2017
Q2 		$3.22M Sell
41,363
-5,055
-11% -$362K 0.07% 500
2017
Q1 		$3.34M Buy
46,418
+29,148
+169% +$2.01M 0.07% 473
2016
Q4 		$1.07M Sell
17,270
-41,518
-71% -$2.54M 0.03% 652
2016
Q3 		$3.81M Sell
58,788
-27,102
-32% -$1.8M 0.14% 226
2016
Q2 		$5.43M Buy
85,890
+68,559
+396% +$4.04M 0.29% 62
2016
Q1 		$1M Sell
17,331
-63,030
-78% -$3.57M 0.06% 393
2015
Q4 		$4.32M Buy
80,361
+44,310
+123% +$2.5M 0.33% 101
2015
Q3 		$1.84M Sell
36,051
-131,218
-78% -$7.06M 0.29% 93
2015
Q2 		$9.43M Buy
167,269
+63,214
+61% +$3.99M 0.38% 8
2015
Q1 		$7.47M Buy
104,055
+8,338
+9% +$542K 0.3% 27
2014
Q4 		$5.37M Sell
95,717
-14,580
-13% -$761K 0.28% 33
2014
Q3 		$5.43M Buy
+110,297
New +$5.62M 0.42% 38

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

AHL Partners's RMD Position: Q4 2017 in Review

AHL Partners increased its ResMed (RMD) stake by 17% in Q4 2017, buying an estimated $1.28M and bringing the position to 108,861 shares worth $9.22M. The position accounts for 0.14% of the portfolio, ranked #253.

AHL Partners first reported a position in RMD in Q3 2014 and has held it in 14 quarters since. The position peaked at $9.43M in Q2 2015. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

  • AHL Partners held 108,861 shares of ResMed worth $9.22M as of Q4 2017.
  • AHL Partners bought 15,507 ResMed shares in Q4 2017, an estimated $1.28M.
  • ResMed made up 0.14% of AHL Partners's portfolio in Q4 2017, its #253 holding.
  • AHL Partners first reported a position in ResMed in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's ResMed position peaked at $9.43M in Q2 2015.
  • 415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.